Bioequivalence study of finasteride: Determination in human plasma by high-pressure liquid chromatography coupled to tandem mass spectrometry

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 2, 2001, Pages 145-150

  Gatti de Menezes, F ^a   Ribeiro, W ^a   Ifa, D R ^a   Amaral de Moraes, M E ^a   Amaral de Moraes, M O ^a   De Nucci, G ^a  

^a Jesuino Marcondes Machado   (Brazil)

Author keywords

CAS 98319 26 7; Finasteride, bioequivalence, pharmacokinetics; Flaxin

Indexed keywords

FINASTERIDE; FLAXIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG FORMULATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; QUANTITATIVE ASSAY; RANDOMIZED CONTROLLED TRIAL; TANDEM MASS SPECTROMETRY;

EID: 0035110444     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300016     Document Type: Article

References (22)

1. Finasteride: A 5α-reductase inhibitor
2. The effect of finasteride in men with benign prostatic hyperplasia
3. The role of 5α-reductase inhibitors in the treatment of prostate cancer
4. Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer
5. Clinical pharmacokinetics and pharmacodynamics of finasteride
6. 14C]finasteride after oral administration in humans
7. Finasteride: A clinical review
8. Effects of finasteride (MK906), a 5α reductase inhibitor, on circulating androgens in male volunteers
9. Finasteride: The first 5 α-reductase inhibitor
10. Hormonal effects of an orally active 4-azasteroid inhibitor of 5α reductase in humans
11. Effect of MK-906, a specific 5α reductase inhibitor, on serum androgens and androgen conjugates in normal men
12. Review: Validation of bioanalytical methods
13. A strategy for validation of bioanalytical methods
14. High performance liquid chromatography determination of N-(2-methyl-2propyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide, a 4-azasteroid, in human plasma from a Phase 1 study
15. High-performance liquid-chromatographic method for the determination of finasteride [N-t-butyl-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide] in human plasma at therapeutic doses
16. Picogram determination of finasteride in human plasma and semen by high-performance liquid chromatography with atmospheric-pressure chemical-ionization tandem mass spectrometry
17. Matrix effect in quantitative LC-MS-MS analyses of biological fluids: A method for determination of finasteride in human plasma at picogram per millilitre concentrations
18. The quantification of drugs in biological matrices by LC/MS/MS is becoming more usual, improving sensitivity and selectivity of methods
19. Finasteride: A review of its potential in the treatment of benign prostatic hyperplasia
20. Part 320: Bioavailability and bioequivalence requirements
21. In vivo bioequivalence guidances
22. A distribution-free procedure for the statistical analysis of bioequivalence studies